Found in one study, tumor PCs can also stimulate RANKL upregulation while downregulating OPG expression, which has even more severe side effects than in healthy counterparts and asymptomatic MM patients, (Figure 1) [51,69]. The gene discussed is TNFSF11; the disease is Miyoshi myopathy.